EAACI Molecular Allergology User's Guide

Paolo Maria Matricardi(Charité - Universitätsmedizin Berlin), Jörg Kleine‐Tebbe, Hans Jürgen Hoffmann(Aarhus University Hospital), Rudolf Valenta(Medical University of Vienna), Christiane Hilger(Luxembourg Institute of Health), Stephanie Hofmaier(Charité - Universitätsmedizin Berlin), Rob C. Aalberse(Sanquin), Ioana Agache(Transylvania University of Brașov), R Asero(Ospedale San Carlo), Barbara Ballmer‐Weber(University Hospital of Zurich), Domingo Barber(Universidad San Pablo CEU), Kirsten Beyer(Charité - Universitätsmedizin Berlin), Tilo Biedermann(Technical University of Munich), Maria Beatrice Bilò(Ospedali Riuniti di Ancona), Simon Blank(Helmholtz Zentrum München), Barbara Bohle(Medical University of Vienna), Philipp P. Bosshard(University Hospital of Zurich), Heimo Breiteneder(Medical University of Vienna), Helen A. Brough(Guy's Hospital), Luis Caraballo(University of Cartagena), Jean‐Christoph Caubet(University Hospital of Geneva), Reto Crameri(University of Zurich), Janet M. Davies(Queensland University of Technology), Nikolaos Douladiris(National and Kapodistrian University of Athens), Motohiro Ebisawa(National Sagamihara Hospital), Philippe Eigenmann(University Hospital of Geneva), Montserrat Fernández‐Rivas(Hospital Clínico San Carlos), Fátima Ferreira(University of Salzburg), Gabriele Gadermaier(University of Salzburg), Martin Glatz(University Hospital of Zurich), Robert G. Hamilton(Johns Hopkins University), T. Hawranek(Paracelsus Medical University), Peter W. Hellings(Amsterdam UMC Location University of Amsterdam), Karin Hoffmann‐Sommergruber(Medical University of Vienna), Thilo Jakob(Justus-Liebig-Universität Gießen), Uta Jappe(German Center for Lung Research), Marek Jutel(Wroclaw Medical University), Sandip D. Kamath(Australian Institute of Tropical Health and Medicine), Edward F. Knol(University Medical Center Utrecht), Peter Korošec(University Clinic of Pulmonary and Allergic Diseases Golnik), Annette Kuehn(Luxembourg Institute of Health), Gideon Lack(King's College London), Andreas L. Lopata(Wroclaw Medical University), Mika J. Mäkelä(University of Helsinki), M. Morisset(Centre Hospitalier de Luxembourg), Verena Niederberger(Medical University of Vienna), Anna Nowak‐Węgrzyn(Icahn School of Medicine at Mount Sinai), Nikolaos G. Papadopoulos(Manchester Academic Health Science Centre), Elide A. Pastorello(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), G. Pauli(Hôpitaux Universitaires de Strasbourg), Thomas A.E. Platts‐Mills(University of Virginia), Daniela Posa(Charité - Universitätsmedizin Berlin), Lars K. Poulsen(Copenhagen University Hospital), Monika Raulf(Institute for Prevention and Occupational Medicine), J. Sastre(Hospital Universitario Fundación Jiménez Díaz), Enrico Scala(Istituti di Ricovero e Cura a Carattere Scientifico), Johannes Martin Schmid(Aarhus University Hospital), Peter Schmid‐Grendelmeier(University Hospital of Zurich), Marianne van Hage(Karolinska University Hospital), Ronald van Ree(Amsterdam UMC Location University of Amsterdam), Stefan Vieths(Paul Ehrlich Institut), Richard W. Weber(National Jewish Health), Magnus Wickman(Karolinska Institutet), Antonella Muraro(University of Padua), Markus Ollert(University of Southern Denmark)
Pediatric Allergy and Immunology
May 1, 2016
Cited by 905Open Access
Full Text

Abstract

The availability of allergen molecules ('components') from several protein families has advanced our understanding of immunoglobulin E (IgE)-mediated responses and enabled 'component-resolved diagnosis' (CRD). The European Academy of Allergy and Clinical Immunology (EAACI) Molecular Allergology User's Guide (MAUG) provides comprehensive information on important allergens and describes the diagnostic options using CRD. Part A of the EAACI MAUG introduces allergen molecules, families, composition of extracts, databases, and diagnostic IgE, skin, and basophil tests. Singleplex and multiplex IgE assays with components improve both sensitivity for low-abundance allergens and analytical specificity; IgE to individual allergens can yield information on clinical risks and distinguish cross-reactivity from true primary sensitization. Part B discusses the clinical and molecular aspects of IgE-mediated allergies to foods (including nuts, seeds, legumes, fruits, vegetables, cereal grains, milk, egg, meat, fish, and shellfish), inhalants (pollen, mold spores, mites, and animal dander), and Hymenoptera venom. Diagnostic algorithms and short case histories provide useful information for the clinical workup of allergic individuals targeted for CRD. Part C covers protein families containing ubiquitous, highly cross-reactive panallergens from plant (lipid transfer proteins, polcalcins, PR-10, profilins) and animal sources (lipocalins, parvalbumins, serum albumins, tropomyosins) and explains their diagnostic and clinical utility. Part D lists 100 important allergen molecules. In conclusion, IgE-mediated reactions and allergic diseases, including allergic rhinoconjunctivitis, asthma, food reactions, and insect sting reactions, are discussed from a novel molecular perspective. The EAACI MAUG documents the rapid progression of molecular allergology from basic research to its integration into clinical practice, a quantum leap in the management of allergic patients.


Related Papers

No related papers found

Powered by citation graph analysis